Aim Liquidambar orientalis Miller (Altingiaceae) is a relict endemic tree whose resinous exudate, storax, is traditionally used for antiseptic and wound-healing purposes; however, its activity against gynecological cancers is poorly characterized. This study evaluated the cytotoxic, anti-invasive, and apoptosis-related effects of L. orientalis storax on MDAH-2774 human ovarian cancer cells. Methods Cell viability was assessed using the XTT assay. Clonogenic survival, migration, and invasion were evaluated using colony formation, wound-healing, and Matrigel invasion assays. Apoptosis was examined by TUNEL staining, and the expression of apoptosis- and cell cycle–related genes was analyzed by quantitative real-time PCR. Results The storax preparation reduced cell viability across the tested concentrations and exposure times, with a 24-h IC₅₀ of 32.34 μg/mL. Treatment decreased colony formation by 24.5% and reduced the invasion rate from 72.4% to 38.4%, while wound-healing assays showed marked suppression of migration. The apoptotic index increased from 3.02% to 11.00%. Storax significantly upregulated the pro-apoptotic and death-receptor genes APAF1, BID, CASP10, FADD, FAS, TNF, and TRADD, and downregulated the anti-apoptotic gene BCL-XL. Conclusion L. orientalis storax preparation was associated with reduced cell viability, clonogenic growth, migration, and invasion in MDAH-2774 cells, along with an apoptosis-related response. These in vitro findings support further investigation of its selectivity and underlying mechanisms.
No takes yet. Share an insight, caveat, or question.
Kabukçu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: